{
    "table_id": "finqa_c3c622bd7f",
    "source": "finqa",
    "original_metadata": {
        "source_dataset": "finqa",
        "document_id": "BDX/2016/page_62.pdf-1",
        "pre_text_caption_evidence": [
            "notes to consolidated financial statements 2014 ( continued ) becton , dickinson and company ( b ) these reclassifications were recorded to interest expense and cost of products sold .",
            "additional details regarding the company's cash flow hedges are provided in note 13 .",
            "on august 25 , 2016 , in anticipation of proceeds to be received from the divestiture of the respiratory solutions business in the first quarter of fiscal year 2017 , the company entered into an accelerated share repurchase ( \"asr\" ) agreement .",
            "subsequent to the end of the company's fiscal year 2016 and as per the terms of the asr agreement , the company received approximately 1.3 million shares of its common stock , which was recorded as a $ 220 million increase to common stock in treasury .",
            "note 4 2014 earnings per share the weighted average common shares used in the computations of basic and diluted earnings per share ( shares in thousands ) for the years ended september 30 were as follows: ."
        ],
        "question": "as of september 30 ,2014 what was the percent of the total average common and common equivalent shares outstanding 2014 assuming dilution that was dilute share equivalents from share-based plans"
    },
    "dimensions": {
        "rows": 3,
        "columns": 4
    },
    "schema": {
        "columns": [
            "",
            "2016",
            "2015",
            "2014"
        ],
        "dtypes": {
            "": "object",
            "2016": "object",
            "2015": "object",
            "2014": "object"
        }
    }
}